Shire Pharmaceuticals announced today the initiation of a voluntary recall in the United States of one batch, packaged into three lots, of VPRIV due to the presence of visible particulate matter, identified as stainless steel and barium sulfate. The particulate matter was found in a small number...
Shire Pharmaceuticals Initiates Voluntary Nationwide Recall of One Batch, Packaged into Three Lots, of VPRIV® (velaglucerase alfa for injection)
Friday, March 14, 2014
Shire Pharmaceuticals Initiates Voluntary Nationwide Recall of One Batch, Packaged into Three Lots, of VPRIV® (velaglucerase alfa for injection)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment